Healthcare
Alector, Inc.
ALEC$2.40+6.19%
Price is delayed.
Add to Watchlist
About Alector, Inc.
Alector is a biotechnology company developing medicines to slow or stop brain diseases like Alzheimer's and Parkinson's disease. The company is still testing its drugs in clinical trials and has not yet brought any medicines to market. Most of its experimental treatments use genetic approaches to reduce the buildup of harmful proteins in the brain. Alector is working with the pharmaceutical company GlaxoSmithKline on some of these drug candidates.
Loading chart...
Members only
Full research is for ConvictionStocks members
Members read the rest of this page. Where we have it for this company, that is:
- What each number means, in plain English, with the Wall Street name where the two differ.
- A plain-English summary of the company.
- How many analysts cover it, and the count behind each rating.
- Recent news, dated.
Get the free weekly market digest
The week's biggest movers, every Sunday. No spam.
Look up another company
Related Research
More Healthcare stocks to explore